Investigation looking into abuse of Israeli drugmaker's dominant market position; pharmaceutical company was sued in the US for price-fixing of same medicine

Bloc accuses the Israeli pharma firm of colluding with a drugmaker it now owns to keep a generic version of modafinil off the market

Israeli pharmaceutical giant takes a gamble that Trump's Justice Department won't file charges after company helps during pandemic

Tentative agreement comes hours ahead of federal trial with allegations that distributors failed to stop suspicious orders of drugs from being shipped despite warnings of misuse

Tens of billions of dollars at stake after failure of last-minute efforts to reach settlement between companies and plaintiffs

The drugmaker, already struggling to cut costs in order to meet debt repayments, may face billions of dollars in fines

Israeli generic drug manufacturer named as 'consistent participant' in conspiracies to raise prices, sometimes by more than 1000%; executives said to have obstructed investigation